Not exact matches
In December, Tehrani signed a deal
with GlaxoSmithKline that will allow the pharmaceutical giant to test at least four of its drug candidates on a Zymeworks -
designed platform, which combines a computer simulation
with a way of engineering protein molecules and allows products to be refined before they move to expensive
clinical trials.
But the short answer for anyone who doesn't want to buy a book is that the standard old - fashioned
clinical trial is
designed to answer a specific question about a population
with lots of different specific characteristics.
These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from
clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree
with our regulatory approval strategies or components of our filings for our products, including our
clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine;
clinical development activities may not be completed on time or at all; the results of our
clinical development activities may not be positive, or predictive of real - world results or of results in subsequent
clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company
with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.
Many have used this data in
designing new methods to supplement and even replace
clinical trials, which are notoriously difficult to fill
with patients.
«It essentially gives us a periodic table,» Ron DePinho, President of MD Anderson Cancer Center says, which has provided us
with both diagnostic and therapeutic value as well as helped us
design clinical trials to accelerate the development of new cancer drugs,».
The candidate should be experienced
designing and running
clinical trials and interacting
with regulatory authorities.
Amyloid buildup is a key pathological feature of Alzheimer's, and determining the degree to which someone's brain is riddled
with the molecule is essential for
designing effective
clinical trials.
The
clinical trial is
designed to assess safety and activity of escalating doses of the special cells (AST - OPC1) for individuals
with a complete cervical spinal cord injury.
However, as many anti-inflammatory drugs are already available, there may be a relatively short path to
designing clinical trials for drugs that modulate the inflammatory response in people
with neurodegenerative disease.
«Complex models are needed to effectively evaluate PMed study
designs, and this proof - of - concept
trial validates the dog
with cancer as a model for
clinical evaluation of novel PMed approaches,» said Dr. Melissa Paoloni, the study's lead author and former director of the COTC.
In this new study and for the first time, scientists used functional magnetic resonance imaging (fMRI) combined
with a standard
clinical trial design to derive an unbiased brain - based neurological marker to predict analgesia associated
with placebo treatment in patients
with chronic knee osteoarthritis pain.
He, along
with his colleague Mark Rubinstein, Ph.D. also of the Hollings Cancer Center,
designed a
clinical trial that started in 2016.
Researchers are
designing the first
clinical trials of stem cell treatments for fetuses afflicted
with rare bone and blood diseases.
The next step, says Salem, will be to try to correlate these findings
with patient treatment outcomes, initially as a retrospective, or backward looking study, and then hopefully
design a forward looking
clinical trial to determine which treatments may be best for patients
with SBAs.
«The current landscape of stem cell tourism should prompt a re-evaluation of current approaches to study cell - based interventions
with respect to the
design, initiation and conduct of U.S.
clinical trials,» the authors wrote.
«It was clear from our findings that many people
with IBS should have their vitamin D levels tested, and the data suggests that they may benefit from supplementation
with vitamin D. «As a result of this exploratory study, we're now able to
design and justify a larger and more definitive
clinical trial.»
«
With knowledge like this, we can
design clinical trials using JAK inhibitors for SS patients based on their JAK mutations,» said Elenitoba - Johnson.
He's also likely to spur the FDA to follow the course laid out by agency cancer czar Richard Pazdur in speeding new approvals, possibly setting up a special unit aimed at orphan drugs to hasten OKs
with smaller, better
designed clinical trials.
Hodi
designed this investigator - initiated
clinical trial to find out if giving sargramostim along
with ipilimumab would have a synergistic effect against the melanoma — like pressing the immune system's accelerator while releasing the brake.
Some of my duties include the
design, testing, and manufacturing of the product; working
with the contractors and
clinical -
trials teams; and exploring different distribution systems.
Working
with the pharma and biotech industries, Poirier focuses on both performing the genetic tests in his laboratory and
designing the
clinical drug
trials.
It was conducted under a special protocol assessment
with the US Food and Drug Administration, which considers an uncompleted Phase III
trial's
design,
clinical endpoints, and statistical analyses acceptable for FDA approval.
But he says their findings may have more immediate implications as well, for the
design of
clinical trials evaluating the benefits of providing nutrients to patients
with sepsis.
Angélica Nogueira - Rodrigues, MD, PhD, of the Brazilian National Cancer Insitute, and her colleagues
designed a phase 2
clinical trial to test the potential of the EFGR inhibitor erlotinib combined
with chemoradiation therapy in 36 women
with cervical cancer.
Appel and Sacks led three earlier
clinical trials that tested ways to reduce the risk of cardiovascular disease and diabetes, providing volunteers
with carefully
designed diets and measuring the effects on key health indicators.
This study was
designed to use readily available agents in an accepted large - animal model of human heart attack
with the goal of obtaining evidence that this treatment is ready to be moved into human
clinical trials.»
Described this week in the New England Journal of Medicine (July 4, 2013 print issue), the
clinical trial was conducted at multiple sites in China and
designed in partnership
with a physician at UC San Francisco.
Two years ago, Bouton and his team began collaborating
with Ohio State neuroscience researchers and clinicians Dr. Ali Rezai and Dr. Jerry Mysiwto
design the
clinical trials and validate the feasibility of using the Neurobridge technology in patients.
Innovative
clinical trial approaches that have proven successful in other disease areas such as oncology (e.g., platform
trials, umbrella and basket
designs) might be employed
with stratification of subjects by AT (N) profile, enabling a data - driven approach to identify the biological stage of disease in which an intervention has maximal treatment effects.
However, in this Phase II
clinical trial,
designed to prospectively evaluate the safety and effectiveness of ACHT for patients
with HIV - related lymphoma, researchers discovered that this population had no greater likelihood of developing these complications compared to those without the virus.
«This is the first human
trial of this novel stem cell - based implant, which is
designed to replace a single - cell layer that degenerates in patients
with dry age - related macular degeneration,» says lead author and surgeon for the study Dr. Amir H. Kashani, assistant professor of
clinical ophthalmology at the Keck School of Medicine of USC.
Biostatisticians and bioinformaticians must have a high level of understanding of the research question being asked, and
design the
trial accordingly
with the information available, setting reasonable expectations for a new treatment based on input from the
clinical investigator.
On the other hand, first
clinical trials with drugs
designed to target cancer stem cells are now under way, so far yielding moderately positive results.
Table 1: Selection,
Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection,
Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection,
Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection,
Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection,
Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection,
Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored
Clinical Trials of T - Vec Table 8:
Clinical Trials of ColoAd1 Table 9:
Clinical Trials with JX - 594 Table 10:
Clinical Trials with GL - ONC1 Table 11:
Clinical Trials of CAVATAK (CVA21) Table 12:
Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study
Design of Oncolytic Viruses in Late Stage Development Based on Previous
Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active
Clinical Studies of Oncolytic Viruses in Combination
with Immune Checkpoint Inhibitors (ICI) Table 18: Planned
Clinical Studies of Oncolytic Viruses in Combination
with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned
Clinical Studies of Oncolytic Viruses in Combination
with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed
Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech
with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions
As a Web Applications Engineer he contributes extensive experience
with relational database technologies such as MySQL, MSSQL and Oracle to the development and
design of the
Clinical Trials Registry and Internet Stroke Center web applications.
Early anti-pseudomonal acquisition in young patients
with cystic fibrosis: rationale and
design of the EPIC
clinical trial and observational study».
Before joining IDRI, Tracey worked as a Protocol Development Manager
with the HIV Vaccine
Trials Network at the Fred Hutchinson Cancer Research Center where she led multi-disciplinary teams in the design and implementation of clinical trials evaluating candidate HIV and tuberculosis vac
Trials Network at the Fred Hutchinson Cancer Research Center where she led multi-disciplinary teams in the
design and implementation of
clinical trials evaluating candidate HIV and tuberculosis vac
trials evaluating candidate HIV and tuberculosis vaccines.
Our program is collaborating
with researchers around the globe to dissect the results from this
trial to inform basic research and
design future
clinical trials to translate a scientific milestone into an eventual public health tool.
May 3, 2006 deCODE genetics (Nasdaq: DCGN) today announced that it has reached an agreement
with the US Food and Drug Administration (FDA) on the
design of its Phase III
clinical trial for DG031, deCODE's lead developmental compound for the prevention of heart attack...
With carefully designed Phase I clinical trials, they begin with small, effective doses and gradually increase to determine the correct dosage and to observe the toxicity of new therap
With carefully
designed Phase I
clinical trials, they begin
with small, effective doses and gradually increase to determine the correct dosage and to observe the toxicity of new therap
with small, effective doses and gradually increase to determine the correct dosage and to observe the toxicity of new therapies.
CancerNetwork speaks
with Patricia S. Steeg, PhD, who has recently written a perspective in the journal Nature calling for a shift in both the types of drugs that are developed for breast cancer and in the way
clinical trials are
designed and executed.
Immune
Design entered into a
clinical trial collaboration
with Genentech, a member of the Roche Group, to evaluate the safety and efficacy of its CMB305 cancer immunotherapy product candidate combined
with the investigational cancer immunotherapy atezolizumab in a randomized Phase 2
trial in patients
with soft tissue sarcoma.
Immune
Design entered into
clinical collaboration agreements
with Merck, known as MSD outside the U.S. and Canada, to evaluate the safety and efficacy of two Immune
Design immuno - oncology investigative agents, G100 and LV305, separately combined
with KEYTRUDA ® (pembrolizumab), Merck's anti-PD-1 therapy, in Phase 1
trials in patients
with non-Hodgkin's lymphoma (NHL) and melanoma, respectively.
She
designs and leads
clinical trials, and works
with both laboratory and public health investigators.
In fact, Morgan, Palinkas, Barrett - Connor, and Winged (1993) articulate this
with, «In several
clinical trials of interventions
designed to lower plasma cholesterol, reductions in coronary heart disease mortality have been offset by an unexplained rise in suicides and other violent deaths» (p. 75).
Providing guidance
with respect to
clinical trial design including: formulation of a testable hypothesis; determination of patient entry criteria; selection of appropriate toxicity assessments; review of appropriate statistical end points; development of an accurate budget
The mission of Animal
Clinical Investigation LLC is to help in the development of new treatment opportunities for pet animals with cancer through the design and implementation of prospective clinical
Clinical Investigation LLC is to help in the development of new treatment opportunities for pet animals
with cancer through the
design and implementation of prospective
clinicalclinical trials.
Safety considerations in the
design and interpretation of
clinical trials indicates that «some animal studies have suggested the potential for dose - dependent fetal toxicities (for example, growth impairment, skeletal malformations and cardiovascular anomalies) associated
with excess Vitamin D supplementation.
Results of this study will be used to help
design future
clinical trials evaluating VSV - IFNβ - NIS in dogs
with relapsed or refractory cancer.
Operationalized Phase III & IV
clinical trials with responsibility for protocol
designs, site and vendor selection, resulting in on - time delivery of
clinical study results.